Loading viewer...
earnings
Format: PDF earnings
Seagen presents fourth quarter and full year 2022 financial results and business updates, including commercial performance of key oncology products ADCETRIS, PADCEV, TUKYSA, and TIVDAK. The presentation covers financial performance, research and development progress, and 2023 outlook with anticipated product sales, regulatory milestones, and clinical trial activities.
earnings
31 Pages
Regis Healthcare
Occidental Petroleum Q2 2023 Earnings Conference Call
earningsearnings
40 Pages
Occidental Petroleum Corporation
JLL Q1 2023 Earnings Presentation
earningsearnings
26 Pages
Jones Lang LaSalle
ICE Third Quarter 2016 Earnings Call Presentation
earningsearnings
20 Pages
ICE (Intercontinental Exchange)